Patents Assigned to Unimed Pharmaeuticals, LLC
  • Testosterone gel and method of use
    Patent number: 8729057
    Abstract: The present invention relates to an improved transdermal hydroalcoholic testosterone gen formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: May 20, 2014
    Assignees: Unimed Pharmaeuticals, LLC, Besins Healthcare Luxembourg SARL
    Inventors: Ramana Malladi, Jodi Stahlman